| Literature DB >> 35405010 |
Scott Barish1,2, Mumine Senturk1,2,3,4, Kelly Schoch5, Amanda L Minogue4,6, Diego Lopergolo7,8,9, Chiara Fallerini7,8, Jake Harland1,2, Jacob H Seemann6, Nicholas Stong10, Peter G Kranz11, Sujay Kansagra12, Mohamad A Mikati12, Joan Jasien12, Mays El-Dairi13, Paolo Galluzzi14, Francesca Ariani7,8,9, Alessandra Renieri7,8,9, Francesca Mari7,8,9, Michael F Wangler1,2,4, Swathi Arur6, Yong-Hui Jiang5,15, Shinya Yamamoto1,2,4,16, Vandana Shashi5, Hugo J Bellen1,2,3,4,16.
Abstract
DROSHA encodes a ribonuclease that is a subunit of the Microprocessor complex and is involved in the first step of microRNA (miRNA) biogenesis. To date, DROSHA has not yet been associated with a Mendelian disease. Here, we describe two individuals with profound intellectual disability, epilepsy, white matter atrophy, microcephaly and dysmorphic features, who carry damaging de novo heterozygous variants in DROSHA. DROSHA is constrained for missense variants and moderately intolerant to loss-of-function (o/e = 0.24). The loss of the fruit fly ortholog drosha causes developmental arrest and death in third instar larvae, a severe reduction in brain size and loss of imaginal discs in the larva. Loss of drosha in eye clones causes small and rough eyes in adult flies. One of the identified DROSHA variants (p.Asp1219Gly) behaves as a strong loss-of-function allele in flies, while another variant (p.Arg1342Trp) is less damaging in our assays. In worms, a knock-in that mimics the p.Asp1219Gly variant at a worm equivalent residue causes loss of miRNA expression and heterochronicity, a phenotype characteristic of the loss of miRNA. Together, our data show that the DROSHA variants found in the individuals presented here are damaging based on functional studies in model organisms and likely underlie the severe phenotype involving the nervous system.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35405010 PMCID: PMC9433733 DOI: 10.1093/hmg/ddac085
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 5.121